|
Transplantation
Citations 411-420 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction
- Katharina Fleischhauer, Franco Locatelli, Marco Zecca, Maria Grazia Orofino, Claudio Giardini, Piero De Stefano, Andrea Pession, Angela Maria Iannone, Carlo Carcassi, Elisabetta Zino, and Giorgio La Nasa
Blood 2006; 107: 2984-2992.
[Abstract]
[Full text]
[PDF]
Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations
- Chunyan Zhang, Ivan Todorov, Zhifang Zhang, Yinping Liu, Fouad Kandeel, Stephen Forman, Samuel Strober, and Defu Zeng
Blood 2006; 107: 2993-3001.
[Abstract]
[Full text]
[PDF]
Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation
- Hermann Einsele, Pierre Reusser, Martin Bornhäuser, Peter Kalhs, Gerhard Ehninger, Holger Hebart, Yves Chalandon, Nicolaus Kröger, Bernd Hertenstein, and Frank Rohde, for the EBMT Working Group on Infectious Disease
Blood 2006; 107: 3002-3008.
[Abstract]
[Full text]
[PDF]
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma
- Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, Benedikt Gahn, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, and Michael Kneba
Blood 2006; 107: 2271-2278.
[Abstract]
[Full text]
[PDF]
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation
- Carolina Berger, Mary E. Flowers, Edus H. Warren, and Stanley R. Riddell
Blood 2006; 107: 2294-2302.
[Abstract]
[Full text]
[PDF]
Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus
- Olaf Beck, Max S. Topp, Ulrike Koehl, Emmanuel Roilides, Maria Simitsopoulou, Mitra Hanisch, Jacqueline Sarfati, Jean Paul Latgé, Thomas Klingebiel, Hermann Einsele, and Thomas Lehrnbecher
Blood 2006; 107: 2562-2569.
[Abstract]
[Full text]
[PDF]
Interferon- -stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
- John Stagg, Sandra Pommey, Nicoletta Eliopoulos, and Jacques Galipeau
Blood 2006; 107: 2570-2577.
[Abstract]
[Full text]
[PDF]
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation
- Stefan O. Schönland, Henk Lokhorst, Agnes Buzyn, Veronique Leblond, Ute Hegenbart, Giuseppe Bandini, Andrew Campbell, Enric Carreras, Augustin Ferrant, Leanthe Grommisch, Peter Jacobs, Nicolaus Kröger, Giorgio La Nasa, Nigel Russell, Pierre Zachee, Hartmut Goldschmidt, Simona Iacobelli, Dietger Niederwieser, and Gösta Gahrton, for the Chronic Leukemia Working Party (CLWP), Myeloma Subcommittee of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)
Blood 2006; 107: 2578-2584.
[Abstract]
[Full text]
[PDF]
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study
- Michael Boeckh, Hyung W. Kim, Mary E. D. Flowers, Joel D. Meyers, and Raleigh A. Bowden
Blood 2006; 107: 1800-1805.
[Abstract]
[Full text]
[PDF]
Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence
- Minoo Battiwalla, Theresa Hahn, Marija Radovic, Hilary Roy, Afrin Wahab, Eileen Duman, Rajinder Bajwa, Swaminathan Padmanabhan, Joanne Becker, A. John Barrett, and Philip L. McCarthy, Jr
Blood 2006; 107: 1970-1973.
[Abstract]
[Full text]
[PDF]
|
|
